Benefits of Vorinostat in Treating Advanced Cutaneous T-Cell Lymphoma

Oncology & Hematology Review (US)
doi 10.17925/ohr.2009.05.1.27
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Touch Medical Media, Ltd.

Related search

Vorinostat for the Treatment of Bullous Pemphigoid in the Setting of Advanced, Refractory Cutaneous T-Cell Lymphoma

Archives of Dermatology
2009English

Trends in the Treatment of Cutaneous T-Cell Lymphoma &Ndash; Critical Evaluation and Perspectives on Vorinostat

Blood and Lymphatic Cancer: Targets and Therapy
2012English

Cutaneous T Cell Lymphoma (Mycosis Fungoides)

JMS SKIMS
2010English

Cutaneous T-Cell Lymphoma (Mycosis Fungoides)

Medical Journal Armed Forces India
Medicine
2007English

Lack of Suppressive CD4+CD25+FOXP3+ T Cells in Advanced Stages of Primary Cutaneous T-Cell Lymphoma

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2006English

Infectious Complications of Cutaneous T-Cell Lymphoma

Cancer Control
MedicineOncologyHematology
2001English

Cutaneous T-Cell Lymphoma With Nasal Necrosis

Archives of Plastic Surgery
Surgery
2015English

Cutaneous T-Cell Lymphoma Imitating Gelsolin Amyloidosis

Neurology
Neurology
2003English

Treatment of Cutaneous T-Cell Lymphoma: An Update

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy